Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TXG
10X GENOMICS, INC.
NASDAQ
$61.54
▼ DOWN 5.10% (-3.31)

KEY STATISTICS

Market Cap$7.81 B
52w High$66.94
52w Low$11.16
Dividend Yield—
Frequency—
P/E-104.31
Volume2.36M
Shares Out.126.96M

COMPANY

LEADERSHIP

Serge Saxonov
CHIEF EXECUTIVE
Serge Saxonov

COMPENSATION 2026

Salary$674,250
Stock Awards$5,020,269
Incentive Plan Pay$634,725
All Other Comp.$0
Total$6,329,244

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 12, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,178

PRICE TARGET

Target High$65.00
Target Low$40.00
Target Median$47.00
Target Consensus$48.86

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$147.21M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2006-07-17Reverse1:2

PRICE

$61.54 ▼ DOWN 5.10% (−$3.31)
OVERLAYS
$61.00$62.00$63.00$64.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM61.54

About 10x Genomics, Inc.

https://www.10xgenomics.com ↗

10x Genomics, Inc. develops and sells instruments, consumables, and software for single-cell and spatial genomic analysis across global research, biotech, and pharma institutions.

INDUSTRY

Medical - Healthcare Information Services

A PRODUCT 10X GENOMICS, INC. IS KNOWN FOR

Chromium GEM-X Single Cell Gene Expression Flex
Chromium GEM-X Single Cell Gene Expression Flex

A cost-effective, high-throughput single-cell transcriptomics assay compatible with 10x Genomics' Chromium X, enabling large-scale, flexible studies across diverse sample types at just one cent per cell.

COMPETITORS

COMPETITOR
BDX COMPARE
ILMN COMPARE
PACB COMPARE
QGEN COMPARE
TECH COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product And Service Revenue$148.02M $165.69M ▲$149.9M ▼$149.09M ▼
Consumables$127.89M $141.75M ▲$129.8M ▼$130.75M ▲
Service$8.13M $8.47M ▲$8.83M ▲$10.68M ▲
Instruments$12M $15.47M ▲$11.26M ▼$7.66M ▼
Licensing And Royalty Revenue$983K $341K ▼$947K ▲$1.94M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
Americas$79.87M $82.17M ▲$80.1M ▼$85.03M ▲
UNITED STATES$77.25M $269.27M ▲$76.69M ▼$82.11M ▲
EMEA$41.62M $53.46M ▲$36.85M ▼$39.97M ▲
CHINA$15.19M $15.02M ▼$15.84M ▲$14.97M ▼
Asia Pacific Excluding China$12.32M $15.37M ▲$18.05M ▲$11.07M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
200
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.01% · 3.5M
ARKG
9.44% · 3.1M
XSU.TO
0.24% · 3.1M
SCHA
0.16% · 555.4K
DFMC
0.32% · 386.5K
PSC
0.88% · 378.6K
FMDE
0.26% · 333.8K
JTEK
0.38% · 273.1K
TMSL
0.51% · 236.8K
CPAI
3.41% · 229.4K
R2US.L
0.24% · 222.2K
FTXH
1.21% · 199.0K
PRFZ
0.43% · 188.4K
AVSC
0.27% · 129.1K
CLSE
0.85% · 118.7K
XRSG.L
0.24% · 108.6K
GSSC
0.50% · 84.9K
GNOM
5.48% · 80.7K
PINK
1.18% · 72.0K
JSML
1.05% · 61.3K
FSML
1.88% · 43.8K
ETHO
0.84% · 26.7K
HY
HYP
2.15% · 23.9K
HGRO
0.78% · 16.1K
WDNA.L
2.65% · 13.9K
RTWP.L
0.37% · 12.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
75.18%
HOLDERS
538
TOP 12 OF 538 · RANKED BY POSITION SIZE
Fmr LLC
17.7M sh · $376.64M
Vanguard Group Inc
13.3M sh · $155.18M
Ark Investment Management LLC
12.7M sh · $206.6M
Blackrock, Inc.
10.8M sh · $414.23M
Blackrock Inc.
6.4M sh · $124.34M
Nikko Asset Management Americas, Inc.
5.5M sh · $89.42M
Quantinno Capital Management LP
5.5M sh · $209.71M
Millennium Management LLC
5.4M sh · $63.57M
Sumitomo Mitsui Trust Holdings, Inc.
5.4M sh · $62.91M
Price T Rowe Associates Inc /Md/
4.5M sh · $174.03M
Wellington Management Group Llp
4.3M sh · $50.1M
Goldman Sachs Group Inc
4.0M sh · $84.32M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Saxonov Serge
Sale · 3.5K shares
2026-08-26
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Saxonov Serge
Sale · 6.5K shares
2026-08-26
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Saxonov Serge
Sale · 492 shares
2026-08-26
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Saxonov Serge
Sale · 18.5K shares
2026-08-24

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 5
OVERWEIGHT 2
BUY 2
EQUAL WEIGHT 1
MARKET PERFORM 1
OUTPERFORM 1
HOLD 1
13 GRADES IN THE LAST 12 MONTHS
Stephens & Co. OVERWEIGHT Canaccord Genuity BUY Piper Sandler NEUTRAL Citigroup NEUTRAL Morgan Stanley EQUAL WEIGHT Leerink Partners MARKET PERFORM Barclays OVERWEIGHT JP Morgan NEUTRAL

SECTORS PEERS

PEERPRICE
GRDN$37.06COMPARE
NUVB$6.66COMPARE
PGNY$26.00COMPARE
OMCL$33.08COMPARE
SDGR$19.70COMPARE
OMDA$23.69COMPARE
CERT$8.35COMPARE
TDOC$6.50COMPARE